Insider · CIK 0001751804

Hamill Laura

Reports to the SEC for 8 companies · DUBLIN 4

sec.gov

Transactions

Companies

Filings

CIK

0001751804

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-31	JAZZJazz Pharmaceuticals plcF Tax Payment	Director	FTax Payment	−1,692 sh	$241.39	−$408K	6,832
2026-08-31	JAZZJazz Pharmaceuticals plcF Tax Payment	Director	FTax Payment	−14 sh	$244.06	−$3,416.9	8,524
2026-08-05	JAZZJazz Pharmaceuticals plcA Award	Director	AAward	+1,605 sh	—	—	8,538
2026-06-12	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+176K sh	—	—	175,800
2025-09-16	Y-mAbs Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−5,825 sh	$8.60	−$50.1K	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−27K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−25.1K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33.5K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.5K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2025-08-08	JAZZJazz Pharmaceuticals plcF Tax Payment	Director	FTax Payment	−1,805 sh	$111.25	−$201K	6,933
2025-08-07	JAZZJazz Pharmaceuticals plcA Award	Director	AAward	+3,507 sh	—	—	8,738
2025-06-30	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+33.5K sh	—	—	33,450
2025-06-30	Y-mAbs Therapeutics, Inc.A Award	Director	AAward	+25.1K sh	—	—	30,905
2024-08-02	JAZZJazz Pharmaceuticals plcA Award	Director	AAward	+3,731 sh	—	—	5,231
2024-06-11	Y-mAbs Therapeutics, Inc.A Award	Director	AAward	+3,495 sh	—	—	5,825
2024-06-11	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+14.5K sh	—	—	14,545
2023-08-31	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−37.5K sh	—	—	0
2023-08-31	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−37.5K sh	—	—	0
2023-08-31	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−75K sh	—	—	0
2023-08-31	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−70.4K sh	—	—	0
2023-06-08	Y-mAbs Therapeutics, Inc.A Award	Director	AAward	+2,330 sh	—	—	2,330
2023-06-08	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	13,950
2023-06-01	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2023-01-17	SCLXScilex Holding Co · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+250K sh	—	—	250,000
2023-01-06	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	Director	AAward	+3,900 sh	—	—	3,900
2023-01-06	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+10.6K sh	—	—	10,600
2022-07-15	Y-mAbs Therapeutics, Inc.Non-Employee Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2022-06-08	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2022-02-10	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+9,200 sh	—	—	9,200
2021-12-23	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−941 sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−9,339 sh	—	—	0
2021-11-19	ACCELERON PHARMA INCU Disposition from Tender	Director	UDisposition from Tender	−474 sh	—	—	0
2021-06-10	Y-mAbs Therapeutics, Inc.Non-Employee Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2021-02-10	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2021-01-29	ACCELERON PHARMA INCA Award	Director	AAward	+474 sh	—	—	474
2021-01-29	ACCELERON PHARMA INCOption to Purchase Common StockA Award	Director	AAward	+941 sh	—	—	941
2020-09-15	ACCELERON PHARMA INCOption to Purchase Common StockA Award	Director	AAward	+9,339 sh	—	—	9,339
2020-06-23	Y-mAbs Therapeutics, Inc.Non-Employee Stock Option (right to buy)A Award	Director	AAward	+32K sh	—	—	32,000
2020-02-12	ANABANAPTYSBIO, INC · Director Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2019-09-24	ANABANAPTYSBIO, INC · Director Stock Option (Right to Buy)A Award	Director	AAward	+2,268 sh	—	—	2,268
2019-09-24	ANABANAPTYSBIO, INC · Director Stock Option (Rigth to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2019-05-08	GILDGILEAD SCIENCES, INC.A Award	EVP, Worldwide Commercial Ops	AAward	+9,840 sh	—	—	9,840
2019-05-08	GILDGILEAD SCIENCES, INC.F Tax Payment	EVP, Worldwide Commercial Ops	FTax Payment	−3,500 sh	$66.07	−$231K	6,340
2019-02-06	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)A Award	EVP, Worldwide Commercial Ops	AAward	+63.1K sh	—	—	63,100
2019-02-06	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitA Award	EVP, Worldwide Commercial Ops	AAward	+13.6K sh	—	—	46,435
2018-10-07	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitA Award	EVP, Worldwide Commercial Ops	AAward	+32.8K sh	—	—	32,795

Recent filings

Accepted (ET)
Sep 24
Hamill Laura0001751804-26-000005
SEC(opens sec.gov)
Aug 74
Hamill Laura0001751804-26-000002
SEC(opens sec.gov)
Jun 154
Hamill Laura0001193125-26-271069
SEC(opens sec.gov)
Sep 194
Hamill Laura0001751804-25-000004
SEC(opens sec.gov)
Aug 114
Hamill Laura0001765581-25-000090
SEC(opens sec.gov)
Jul 24
Hamill Laura0001415889-25-019050
SEC(opens sec.gov)
Aug 64
Hamill Laura0001765581-24-000066
SEC(opens sec.gov)
Jun 134
Hamill Laura0001104659-24-071402
SEC(opens sec.gov)
Aug 314
Hamill Laura0001209191-23-047817
SEC(opens sec.gov)

Companies

Address

5TH FL, WATERLOO EXCHANGE WATERLOO RD

DUBLIN 4